Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Change in Cash (2016 - 2025)

Sangamo Therapeutics (SGMO) has disclosed Change in Cash for 16 consecutive years, with -$9.6 million as the latest value for Q4 2025.

  • For Q4 2025, Change in Cash fell 452.59% year-over-year to -$9.6 million; the TTM value through Dec 2025 reached -$22.5 million, down 583.81%, while the annual FY2025 figure was -$22.5 million, 583.81% down from the prior year.
  • Change in Cash hit -$9.6 million in Q4 2025 for Sangamo Therapeutics, down from -$9.3 million in the prior quarter.
  • Across five years, Change in Cash topped out at $46.9 million in Q2 2021 and bottomed at -$58.6 million in Q1 2022.
  • Average Change in Cash over 5 years is -$5.6 million, with a median of -$8.8 million recorded in 2021.
  • Year-over-year, Change in Cash tumbled 601.64% in 2022 and then surged 225.19% in 2024.
  • Sangamo Therapeutics' Change in Cash stood at $1.9 million in 2021, then soared by 206.26% to $5.9 million in 2022, then crashed by 292.54% to -$11.3 million in 2023, then skyrocketed by 124.02% to $2.7 million in 2024, then tumbled by 452.59% to -$9.6 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$9.6 million, -$9.3 million, and $13.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.